Is Curing Patients a Sustainable Business Model?

This was a question recently posed to "investors" at Goldman/Sachs.
One report stated " The potential to deliver "one shot cures" is one of the most attractive aspects of gene therapies . . . While this proposition carries tremendous value for patients and society it could represent a challenge for genome medicine developers looking for sustained cash flow." A challenge!! To "sustained" cash flow. For medicine.
Well, we sure wouldn't want pharma to have to face any challenges to their profiteering from death and disease now would we.
This is what a "free market" economy creates.
Trumps recent bombing of Syria put a big jump in weapons contractor stocks.
Corporations don't even bother to hide the fact that they look at disaster and death as business opportunities. It's good for GDP and puts money in the pockets of psychopaths. Curing a disease or ending conflict is the last thing they want. Polluted water and air are dollar signs.
They don't even have to worry about govt interference anymore because they own the govt. . Contributions and the promise of a cushy job after their "public service" is more than enough to sway opinion.
Even when they get busted the worst case scenario is a relatively insignificant fine that they consider a cost of doing business to be passed along to the consumer. . They're too big to jail.
So, as the wealth gap continues to explode and 68% of the richest country in the history of the world can't handle a $1000 emergency and as Americans work more hours for less money than they did 30 years ago let's keep telling ourselves how wonderful "free market" Capitalism is. Capitalism is the most destructive force on the planet and it's destroying the world right before our eyes. I hope you like Soylent Green.